Andrew G. King
Department of Microbial
Musculoskeletal
Proliferative Disease Center of Excellence in Drug Discovery (AGK)
GlaxoSmithKline
USA
Name/email consistency: high
- Effect of a selective and potent central nervous system penetrant, neurokinin-3 receptor antagonist (SB-222200), on cisplatin-induced emesis in the ferret. King, A.G., Sanger, G.J. Neurosci. Lett. (2005)